Context
Competitive intelligence at AbbVie involves a systematic, multi-step process that enables the company to make smart decisions, particularly in the high-stakes area of developmental drugs. At a high level, it helps the company:
Stay ahead of competitors
Minimize risk and R&D waste
Have timely patient impact
Problem
Faced with a tedious and fragmented process, it takes AbbVie scientists hours to find up-to-date drug information. This inefficiency slows drug development and poses the risk of costing the company tens of millions of dollars annually.
Outcome
My team and I created a platform that helps 8000+ scientists find up-to-date drug information within seconds, which are used to make strategic business development choices that save the company tens of millions of dollars.
Role
Lead Designer
Duration
Jan - Apr 2024
Team
Research
The client stakeholders aimed to modernize the competitive intelligence workflow to accelerate and improve the drug development process. They mentioned several steps in the workflow as critical pain points that are time consuming and arduous. To validate this assumption and better understand the broader context, my team and I proposed conducting user interviews with scientists to learn how they currently approach competitive intelligence and identify key areas for improvement.
These interviews confirmed several pain points identified by the client stakeholders and surfaced additional insights we hadn't previously considered, including a need for visual representations of drug development data, the ability to annotate findings, and tools to save and share search history among others. To prioritize these ideas, I facilitated a workshop with both our team and client stakeholders, mapping the opportunities on a 2x2 matrix. This helped us align around the features that would deliver the greatest impact in the shortest time and guided the MVP direction.
Beyond the unmet needs revealed in user interviews, we also observed several behavioral challenges scientists faced during their workflow. These were issues that weren’t explicitly stated but became clear through watching how they worked. These behavioral friction points were slowing them down and contributing to inefficiencies in the competitive intelligence process. By identifying and addressing these subtle pain points, we saw an opportunity to meaningfully enhance the workflow and bring us closer to achieving a smoother, more intuitive experience for end users.
🔥
High-Friction When Googling
Scientists noted they felt pressure to work faster and expressed the concern of taking too much time to Google articles and press releases related to competitor drugs.
😖
Low Confidence
Scientists struggled to determine which results warranted deeper review, causing them to either miss important information or spend excessive time researching.
😵💫
Overwhelming Possibilities
Scientists found it daunting to sift through multiple pharmaceutical databases like the National Institute of Health and thousands of Google results at the start of their investigations.
Opportunity
Through observation, we noticed that while scientists could locate relevant content, the tools available to them weren't built for navigating complex medical data. This made the process inefficient and frustrating. Often, scientists relied on Google searches opened in multiple tabs and windows, followed by additional research to verify the credibility of the information they found. This constant switching between sources not only slowed them down but also eroded confidence in their findings.
These behaviors pointed us towards two key user needs. Streamlining the experience and building trust. After getting buy in from our engineers, I proposed consolidating relevant information into a single, unified interface to reduce the number of steps required to build a competitive landscape report, eliminating the need to jump between tools and databases.
To address the lack of trust we observed, we focused on surfacing reliable trust signals within the platform such as publication dates, source links, and confidence scores, so scientists could quickly evaluate the credibility and relevance of data at a glance. By reducing friction and increasing confidence, we aimed to make the competitive intelligence process not just faster, but more dependable as well.
Platform: Data Consolidation Tool
The way scientists begin the competitive intelligence workflow is critical as it shapes how efficiently scientists can produce a comprehensive analysis of competitive landscapes. To reduce friction and make the workflow more enjoyable for our users, I reimagined the way scientists discover and filter information related to developmental drugs.
Previously, scientists had to manually navigate multiple sources, such as the National Institute of Health and other databases, just to piece together basic insights. This not only slowed their progress but also left them overwhelmed by fragmented tools and inconsistent interfaces.
With the Competitive Intelligence Search Tool, we centralized this process. The new search experience pulls relevant data from trusted sources into one cohesive view, enabling scientists to explore, compare, and analyze information without switching between platforms. This shift significantly reduced time spent searching and made it easier to uncover meaningful insights.
Feature: Custom Entry Point
To surface the precise information scientists needed, I designed a powerful and flexible search component tailored specifically for developmental drug research. Rather than relying on a generic search bar, this component was built to reflect how scientists think by offering contextual filters that let users narrow or broaden their search based on their specific goals.
Scientists could input as many or as few parameters as they wanted, giving them control over the depth and scope of their queries. We hypothesized that this level of search customization would reduce the number of steps required to find relevant data and significantly improve the speed and accuracy of the experience.
Early and close collaboration with developers was essential to building this component, as it relied on complex but intuitive interaction design. I worked with the engineering team from the start to explore different interaction models, aligning on what was feasible and user-friendly. Throughout the development process, we continued meeting regularly to review progress and ensure pixel perfect implementation. This tight feedback look allowed us to catch and simplify overly complex interactions early on, which not only improved the user experience but also made implementation smooth and more efficient.
Feature: Tools for Deeper Investigation
To help scientists verify and trust the information they were reviewing, I designed a detailed drug view page optimized for deeper investigation. The goal was to give scientists the context they need at a glance, while still giving them the flexibility to easily pursue additional trust signals if needed. Our hypothesis was that showing these trust signals in one place would increase user confidence in the data and make it easier for scientists to validate or act on the information efficiently.
The information architecture of the page was shaped by early user interviews, combined with design intuition grounded in scientists’ workflows. One of the key insights was that sharing and exporting findings played an essential role in cross-functional collaboration. To support this need, I placed the “Share” and “Export” actions in a prominent position at the top right of the screen, making them easy to access without disrupting the user’s flow.
Below the top actions bar, I presented high-level metadata about the selected drug, disease, or gene to immediately orient users and reinforce the context of their investigation. The rest of the page was divided into tabbed sections, each supporting a deeper layer of research—such as comparing the current asset to in-house products or reviewing related publications.
The “Overview” tab was selected as the default landing tab, as it contains the most frequently referenced content, including the drug’s development timeline and description. This structure allowed scientists to quickly find key information while providing flexible paths for deeper exploration as needed.
Summary
By the end of the project, we successfully delivered on our north star by creating a platform that reduces the effort required to generate competitive landscape reports and removes key friction from the competitive intelligence workflow.
The platform also increases user confidence by surfacing trust signals like source links, publication dates, and validation statuses—helping scientists make decisions with greater speed and assurance.
Scientists can now search for developmental drug information using flexible inputs, enabling quick comparisons and deeper exploration of individual compounds. What was once a fragmented, manual process is now centralized, faster, and more intuitive.
We exceeded industry standards with a strong Net Promoter Score of 58 that reflected high user satisfaction and energized the team to pursue additional features scientists had initially requested, including:
Improved performance through deeper engineering collaboration
Real-time alerts to track drug development activity
Drug history comparison tools
Integration with existing AbbVie platforms
Not only do these opportunities inspire more confidence in our users and reduce friction, they offer a clear path to expand the platform’s impact and further support scientists in their decision-making.
Takeaways
This project was a lesson in balancing stakeholder expectations with user needs under tight timelines. While AbbVie came to us with a clear solution in mind and a fast-approaching showcase deadline, early user research revealed gaps between their vision and scientists' actual workflows. Rather than push back entirely, I took a hybrid approach. I moved forward with the core of their concept to meet the immediate goal, while layering in insights from user interviews to shape the design in ways that would be more useable and scalable long-term.
This experience taught me that user-centered design isn’t always about pushing back. Sometimes, it’s about strategic alignment. Meeting stakeholders where they are, building momentum with early wins, and embedding user value incrementally. By doing this, I was able to build trust, gain influence, and pave the way for deeper user validation in future iterations.